Most of these symptoms are mild and tend to resolve as your body adapts
Duration of treatment, behavioural changes made during that time, dietary patterns established, and baseline metabolic health all influence what happens after stopping GLP-1 medication
By interfacing with two incretin hormones, Tirzepatide stands out for its dual mechanism of action, offering an innovative treatment option in the landscape of diabetes and weight management medication
As always, if side effects persist, dont hesitate to speak to your medical provider
The STEP UP trial, published in The Lancet Diabetes & Endocrinology in September 2025, showed 18.7% average weight loss at 72 weeks compared to 15.6% at the standard 2.4 mg dose
However, if it persists, consult your healthcare provider